definiens: means all improvements, modifications, changes or ad!lptation to the Process employed by or on behalf of [COMPANY] which are at any time during the continuance of the Agreement used in the conduct of Manufacture ; 1.1.31 means the forecast provided by [COMPANY] for the utilisation of the Reserved Capacity in the BPMSS and BPMLS for the years 2004 to 2010, as set out in Schedule 3 ; 1.1.32 means an investigational new drug application made to the FDA ; 1.1.33 means samples taken during the Manufacturing Process, including but not limited to samples ofthe bulk Product ; 1.1.34 means the weekly rate for Reserved Capacity Batches ( including Engineering Batches, if any ) in either the BPMLS or BPMSS as set out in Schedule 1 . The Introductory Rate shall apply to the Initial Forecast, as varied pursuant to Clause 9.2 ; 1.1.35 means any Improvements, whether patentable or otherwise, developed by [COMPANY] under this Agreement as a direct result of its performance of the Services ; 1.1.36 means all technical and other information relating to the manufacture of pharmaceutical products known to [COMPANY] other than [COMPANY] Know - How ; 1.1.37 means any patent or patent application owned by or licensed to [COMPANY] necessary for the Manufacture of Product ; 1.1.38 means [COMPANY] Know - How and [COMPANY] Patents ; 4 _ _ _ _ _ _ _ _ _ _ _ Delta View comparison of iManageDeskSite:1 INYDMSO IINYDOCS/115899811 and iManageDeskSite:1 INYDMSOIINYDOCSI1158998/2 . Performed on 6/2112004